Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT04464122 · clinicaltrials.gov ↗

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Neuroendocrine Neoplasm
Neuroendocrine Tumor Grade 1
Neuroendocrine Tumor Grade 2
Neuroendocrine Carcinoma

Interventions

DRUG: Somatostatin analog; chemotherapy

Sponsor

University of Roma La Sapienza